Evidence map›Paper›PMID 28498846›Full record

ArticlePLoS genetics2017

MeCP2 recognizes cytosine methylated tri-nucleotide and di-nucleotide sequences to tune transcription in the mammalian brain.

Sabine Lagger, John C Connelly, Gabriele Schweikert, Shaun Webb, Jim Selfridge, Bernard H Ramsahoye, Miao Yu, Chuan He, Guido Sanguinetti, Lawrence C Sowers and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
15.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 150 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Sabine LaggerWellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh, United Kingdom.ORCID http://orcid.org/0000-0002-3032-9910
John C ConnellyWellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh, United Kingdom.ORCID http://orcid.org/0000-0002-6899-1870
Gabriele SchweikertWellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh, United Kingdom.
Shaun WebbWellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh, United Kingdom.ORCID http://orcid.org/0000-0002-4956-3766
Jim SelfridgeWellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh, United Kingdom.
Bernard H RamsahoyeInstitute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Miao YuDepartment of Chemistry and Institute for Biophysical Dynamics, University of Chicago, Chicago, Illinois, United States of America.
Chuan HeDepartment of Chemistry and Institute for Biophysical Dynamics, University of Chicago, Chicago, Illinois, United States of America.
Guido SanguinettiSchool of Informatics, University of Edinburgh, Edinburgh, United Kingdom.
Lawrence C SowersDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Malcolm D WalkinshawCentre for Translational and Chemical Biology, University of Edinburgh, Edinburgh, United Kingdom.
Adrian BirdWellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh, United Kingdom.ORCID http://orcid.org/0000-0002-8600-0372
Wellcome Centre for Cell Biology · GBHoward Hughes Medical Institute · USUniversity of Edinburgh · GBInstitute of Genetics and Cancer · GBThe University of Texas Medical Branch at Galveston · US

Funding

Oxidation of 5-methylcytosine: DNA damage and epigenetic reprogrammingR01CA184097 · NCI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI SOWERS, LAWRENCE C, ZHANG, KANGLING · 2014 to 2018
$1.6M
Medical Research Council G0800401NCI NIH HHS R01 CA184097Wellcome Trust 107930/Z/15/Z
6 · The paper itself

Abstract

Mutations in the gene encoding the methyl-CG binding protein MeCP2 cause several neurological disorders including Rett syndrome. The di-nucleotide methyl-CG (mCG) is the classical MeCP2 DNA recognition sequence, but additional methylated sequence targets have been reported. Here we show by in vitro and in vivo analyses that MeCP2 binding to non-CG methylated sites in brain is largely confined to the tri-nucleotide sequence mCAC. MeCP2 binding to chromosomal DNA in mouse brain is proportional to mCAC + mCG density and unexpectedly defines large genomic domains within which transcription is sensitive to MeCP2 occupancy. Our results suggest that MeCP2 integrates patterns of mCAC and mCG in the brain to restrain transcription of genes critical for neuronal function.

Indexed as

Dinucleotide RepeatsDNA MethylationTrinucleotide RepeatsAnimalsBrainCpG IslandsCytosineEpigenesis, GeneticMaleMethyl-CpG-Binding Protein 2MiceMice, Inbred C57BLProtein BindingRett SyndromeCytosineMecp2 protein, mouseMethyl-CpG-Binding Protein 2

Identifiers

PMID28498846
PMCPMC5446194
OpenAlexW2613119278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.